Influence of preoperative preparation on the vaginal architectonics of postmenopausal women with severe genital prolapse

Cover Page

Abstract


Patients with severe postmenopausal genital prolapse (GP) are the most clinically difficult group of women, in which surgical treatment with mesh implants presents significant difficulties due to the duration of lesions amid pronounced structural changes in the tissues of the urogenital tract under conditions of hormone deficiency. That is why it is of particular importance to study the histological characteristics of the vaginal mucosa in women with GP, who must conduct surgical treatment of vaginal access.

Aim. To study the histological features of the vaginal mucosa in postmenopausal women with severe GP in preparation for surgical treatment with vaginal access.

Materials and methods. The study involved 70 postmenopausal women suffering from GP of stage III, IV in combination with genitourinary menopausal syndrome. Patients were randomized blindly into two groups. The therapy was carried out using vaginal forms of estrogen and progesterone preparations in combination with lactobacilli. In the comparison group, preoperative preparation was not performed. All patients underwent clinical and laboratory examination: general examination and gynecological examination, morphological examination of biopsy samples of the mucous membrane of the anterior vaginal wall, which were obtained during subsequent surgical treatment of GP. Methods of parametric statistics were used.

Results. It was established that focal dystrophy, acanthotic severity, keratinization of the vaginal epithelium, moderate inflammation are characteristic morphological changes in the vaginal mucosa in women with postmenopausal GP. Application at the stage of preparation for surgical treatment using vaginal forms, as a result of which estrogen and progesterone enhance the inflammatory process in the ulcerative vagina, reduce dystrophic changes and their severity in relation to complex changes and differentiation of the vaginal epithelium and activation of regeneration processes in tissues.

Conclusion. Reducing inflammation and the severity of dystrophic processes in vaginal enemas at the stage of preoperative preparation of women with postmenopausal GP favorably affects the regeneration processes, which in the first place can improve the outcome of surgical treatment.


Full Text

Restricted Access

About the authors

Mariia V. Lazukina

Ural Research Institute for Maternity and Child Care

Author for correspondence.
Email: masha_balueva@mail.ru
ORCID iD: 0000-0002-0525-0856

Russian Federation, Yekaterinburg

Graduate Student, Ural Research Institute for Maternity and Child Care

Anna A. Mikhelson

Ural Research Institute for Maternity and Child Care

Email: ann_lukach@list.ru
ORCID iD: 0000-0003-1709-6187

Russian Federation, Yekaterinburg

D. Sci. (Med.), Ural Research Institute for Maternity and Child Care

N. V. Bashmakova

Ural Research Institute for Maternity and Child Care

Email: BashmakovaNV@niiomm.ru
ORCID iD: 0000-0002-9938-7684

Russian Federation, Yekaterinburg

D. Sci. (Med.), Prof., Ural Research Institute for Maternity and Child Care

O. A. Melkozerova

Ural Research Institute for Maternity and Child Care

Email: abolmed1@mail.ru
ORCID iD: 0000-0002-4090-0578

Russian Federation, Yekaterinburg

D. Sci. (Med.), Ural Research Institute for Maternity and Child Care

G. N. Chistyakova

Ural Research Institute for Maternity and Child Care

Email: guzel@niiomm.ru
ORCID iD: 0000-0002-0852-6766

Russian Federation, Yekaterinburg

D. Sci. (Med.), Prof., Ural Research Institute for Maternity and Child Care

Anastasiia A. Grishkina

Ural Research Institute for Maternity and Child Care

Email: xumukyc.ru@mail.ru
ORCID iD: 0000-0001-7433-2217

Russian Federation, Yekaterinburg

Research Assistant, Ural Research Institute for Maternity and Child Care

References

  1. Ермакова Е.И. Генитоуринарный менопаузальный синдром: диагностика и принципы лечения. Мед. совет. 2019; 13: 106–11. [Ermakova E.I. Genitourinarnyi menopauzal’nyi sindrom: diagnostika i printsipy lecheniia. Med. sovet. 2019; 13: 106–11 (in Russian).]
  2. Юренева С.В., Ермакова Е.И., Глазунова А.В. Диагностика и терапия генитоуринарного менопаузального синдрома у пациенток в пери- и ¬постменопаузе (краткие клинические рекомендации). Акушерство и гинекология. 2016; 5: 138–44. [Iureneva S.V., Ermakova E.I., Glazunova A.V. Diagnostika i terapiia genitourinarnogo menopauzal’nogo sindroma u patsientok v peri- i postmenopauze (kratkie klinicheskie rekomendatsii). Akusherstvo i ginekologiia. 2016; 5: 138–44 (in Russian).]
  3. Baber RJ, Panay N, Fenton A, the IMS Writing Group. 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy. Climacteric 2016; 19 (2): 109–50.
  4. Setty P, Redekal L, Warren MP. Vaginal estrogen use and effects on quality of lifeand urogenital morbidity in postmenopausal women after publication of the Womens Health initiative in New York City. Menopause 2016; 23 (1): 7–10.
  5. Прилепская В.Н., Назаренко Е.Г. Эстриол в терапии различных гинекологических заболеваний. Мед. совет. 2017; 2: 8–13. [Prilepskaya V.N., Nazarenko E.G. Estriol v terapii razlichnykh ginekologicheskikh zabolevanii. Med. sovet. 2017; 2: 8–13 (in Russian).]
  6. Шкарупа Д.Д., Кубин Н.Д., Попов Э.Н. и др. Передне-апикальная протезирующая реконструкция тазового дна вагинальным доступом с применением сверхлегкого сетчатого имплантата: 2 года наблюдения. Журн. акушерства и женских болезней. 2018; 67 (3): 55–63. [Shkarupa D.D., Kubin N.D., Popov E.N. et al. Peredne-apikal’naia proteziruiushchaia rekonstruktsiia tazovogo dna vaginal’nym dostupom s primeneniem sverkhlegkogo setchatogo implantata: 2 goda nabliudeniia. Zhurn. akusherstva i zhenskikh boleznei. 2018; 67 (3): 55–63 (in Russian).]
  7. Башмакова Н.В., Михельсон А.А., Лазукина М.В. и др. Дискуссионные вопросы предоперационной подготовки и ведения послеоперационного периода женщин с пролапсом гениталий (обзор литературы). Лечение и профилактика. 2018; 8 (2): 43–7. [Bashmakova N.V., Mikhel’son A.A., Lazukina M.V. et al. Diskussionnye voprosy predoperatsionnoi podgotovki i vedeniia posleoperatsionnogo perioda zhenshchin s prolapsom genitalii (obzor literatury). Lechenie i profilaktika. 2018; 8 (2): 43–7 (in Russian).]
  8. Тотчиев Г.Ф., Токтар Л.Р., Апокина А.Н. Морфологические и иммуногистохимические критерии тяжести пролапса гениталий. Ульяновский медико-биологический журнал. 2012; 3: 146–9. [Totchiev G.F., Toktar L.R., Apokina A.N. Morfologicheskie i immunogistokhimicheskie kriterii tiazhesti prolapsa genitalii. Ul’ianovskii mediko-biologicheskii zhurnal. 2012; 3: 146–9 (in Russian).]
  9. Рулев М.В. Эффективность хирургического лечения пролапса тазовых органов с использованием синтетического импланта PROLIFT. Автореф. дис. … канд. мед. наук. СПб., 2010. [Rulev M.V. Effektivnost’ khirurgicheskogo lecheniia prolapsa tazovykh organov s ispol’zovaniem sinteticheskogo implanta PROLIFT. Avtoref. dis. … kand. med. nauk. Saint Petersburg, 2010 (in Russian).]
  10. Денисова Т.Б. Оптимизация хирургического лечения женщин с пролапсом тазовых органов. Автореф. дис. … канд. мед. наук. М., 2010. [Denisova T.B. Optimizatsiia khirurgicheskogo lecheniia zhenshchin s prolapsom tazovykh organov. Avtoref. dis. … kand. med. nauk. Moscow, 2010 (in Russian).]
  11. Строни Р. Хирургическое лечение урогенитальных расстройств у женщин в постменопаузальном периоде. Автореф. дис. … канд. мед. наук. М., 2011. [Stroni R. Khirurgicheskoe lechenie urogenital’nykh rasstroistv u zhenshchin v postmenopauzal’nom periode. Avtoref. dis. … kand. med. nauk. Moscow, 2011 (in Russian).]
  12. Оразов М.Р., Демяшкин Г.А., Кампос Е. и др. Ультраструктурные характеристики тканей тазового дна как патогенетическое обоснование применения направленной контактной диатермии при пролапсе тазовых органов. Доктор.ру. Гинекология. Эндокринология. 2017; 8: 40–7. [Orazov M.R., Demiashkin G.A., Kampos E. et al. Ul’trastrukturnye kharakteristiki tkanei tazovogo dna kak patogeneticheskoe obosnovanie primeneniia napravlennoi kontaktnoi diatermii pri prolapse tazovykh organov. Doktor.ru. Ginekologiia. Endokrinologiia. 2017; 8: 40–7 (in Russian).]
  13. Еприкян Е.Г., Юренева С.В., Ермакова Е.И. и др. Генитоуринарный менопаузальный синдром: оптимизация терапии вагинальных симптомов. Гинекология. 2018; 20 (3): 52–6. [Eprikian E.G., Iureneva S.V., Ermakova E.I. et al. Genitourinary menopausal syndrome: optimizing the treatment of vaginal symptoms. Gynecology. 2018; 20 (3): 52–6 (in Russian).]
  14. Прилепская В.Н. Генитоуринарный менопаузальный синдром: возможности эстриола. Гинекология. 2018; 20 (1): 5–9. [Prilepskaya V.N. Genitourinary menopausal syndrome: the potential of estriol. Gynecology. 2018; 20 (1): 5–9 (in Russian).]
  15. Portman DJ. Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women’s Sexual Health and the North American Menopause Society. Maturitas 2014; 79 (3): 349–54.
  16. Тюзиков И.А., Жиленко М.И., Поликарпова С.Р. Современные возможности оптимизации локальной гормонотерапии урогенитальных нарушений у женщин на основе комбинированного применения вагинальных форм эстриола и прогестерона. Гинекология. 2018; 20 (1): 117–25. [Tiuzikov I.A., Zhilenko M.I., Polikarpova S.R. Modern opportunities for optimizing local hormone therapy for urogenital disorders in women based on the combined use of vaginal forms of estriol and progesterone. Gynecology. 2018; 20 (1): 117–25 (in Russian).]

Supplementary files

There are no supplementary files to display.

Statistics

Views

Abstract - 12

PDF (Russian) - 0

Cited-By


PlumX

Dimensions

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies